• OPEN AN ACCOUNT
Indian Indices
Sensex
80,238.85 -1,048.34
( -1.29%)
Global Indices
Nasdaq
48,904.78 -73.14
(-0.15%)
Dow Jones
6,863.50 -36.75
(-0.53%)
Hang Seng
56,282.78 -1,774.46
(-3.06%)
Nikkei 225
10,782.87 -127.68
(-1.17%)
Forex
USD-INR
91.06 0.13
(0.14%)
EUR-INR
107.55 0.22
(0.20%)
GBP-INR
122.70 -0.27
(-0.22%)
JPY-INR
0.58 0.00
(0.12%)

EQUITY - MARKET SCREENER

Smruthi Organics Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
540686
INE172E01011
61.8615202
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
25.55
126.65
EPS(TTM)
Face Value()
Div & Yield %
4.33
10
1.36
 

rossari biotech ltd
NIBE slides after reporting dismal Q3 numbers
Feb 13,2026
Revenue from operations fell 60.3% year-on-year (YoY) to Rs 59.08 crore in the quarter ended 31 December 2025.

The company reported a pre-tax loss of Rs 21.81 crore in Q3 FY26 as compared to a profit before tax of Rs 1.91 crore reported in the same quarter last year.

Total expenses fell 45.15% YoY to Rs 81.39 crore during the quarter. The cost of materials consumed stood at Rs 13.15 crore (up 40.49% YoY), while employee benefit expenses fell 11.02% YoY to Rs 6.70 crore during the period under review.

NIBE operates in manufacturing critical components for the defence sector, electric vehicles (E-Vehicles), and software development. The company is engaged in the fabrication and machining of components used in the defence sector, as well as the assembly of components for E-vehicles.